Pauline Gareau is the Global CBRN Lead at SERB since 2020. SERB is a pharmaceutical company with significant expertise in medical countermeasures, focusing on developing and providing antidotes for different CBRN risks.
Pauline Gareau has a degree in biotechnology engineering and over 10 years of experience in the pharmaceutical industry. She has worked on a variety of projects related to medical countermeasures in Europe and around the world.
She is passionate about providing new and innovative treatments to protect people from CBRN threats. She is also a strong advocate for public health and science education.